FindTrial
Sign In

Antenatal beta carotene supplementation

Antenatal beta carotene supplementation and its effect on placental development and newborn kidney size and function.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009888
Enrollment
Unknown
Registered
2017-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: Beta carotene: Nutritional counselling for 30 women Control Intervention2: Nutritional advice: Nutritional advice and counselling

Sponsors

Sumathi Swaminathan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy pregnant women

Exclusion criteria

Exclusion criteria: mothers who anticipate moving out of the area before study completion, twin or multiple pregnancies, positivity for hepatitis B (HBsAg), HIV or syphilis (VDRL) infections, or those on daily vitamin supplements in addition to folate and iron, and those with serious pre-existing medical conditions that require chronic or daily medical therapy

Design outcomes

Primary

MeasureTime frame
Change in day-3 plasma isotopic ratios before and after interventionTimepoint: Change in day-3 plasma isotopic ratios before and after intervention—

Secondary

MeasureTime frame
Kidney volume at birth Cord Blood Cystatin CTimepoint: 4 months—

Countries

India

Contacts

Public ContactSumathi Swaminathan

St.Johnâ??s Research Institute

sumathi@sjri.res.in08049467000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026